| Line 1: |
Line 1: |
| − | '''Annual Goals:''' | + | '''AY '26-'27 Goals''' |
| − | *Get a manuscript ready for submission | + | *Submit a manuscript for publication |
| − | *RISE 1 application | + | **Meet w/ Nina |
| − | *Identify additional funding sources | + | *Submit RISE 1 application |
| | + | **Think deeply about research directions and goals |
| | + | **Literature review to refine research aims |
| | + | **Figure out organizational system to be more productive with research time |
| | + | **Start identifying mentors |
| | + | *Identify additional funding sources and apply |
| | *Start recruiting a research team | | *Start recruiting a research team |
| − |
| |
| − | '''Monthly Goals:'''
| |
| − | *Meet w/ Nina
| |
| − | *Think deeply about research directions and goals
| |
| − | *Literature review to refine research aims
| |
| − | *Figure out organizational system to be more productive with research time
| |
| − | *Start identifying mentors
| |
| | | | |
| | == 9/22 == | | == 9/22 == |
| Line 28: |
Line 26: |
| | **20 years ago he licensed some PK/PD software to GE but no one bought it. A Norwegian company tried the same thing, also without success. He is now trying to get it integrated into EPIC. Is it just a marketing problem that no one wants to buy it? They've shown that it changes how people deliver anesthesia (typically they use less, specifically opioid). | | **20 years ago he licensed some PK/PD software to GE but no one bought it. A Norwegian company tried the same thing, also without success. He is now trying to get it integrated into EPIC. Is it just a marketing problem that no one wants to buy it? They've shown that it changes how people deliver anesthesia (typically they use less, specifically opioid). |
| | **He thinks the big thing that is lacking from Christian's research is volunteer studies. | | **He thinks the big thing that is lacking from Christian's research is volunteer studies. |
| | + | **He did a bunch of PD studies looking at responses to different noxious stimuli at various effect site concentrations. Still has the equipment. |
| | | | |
| | *Read through the RISE application. | | *Read through the RISE application. |
| Line 59: |
Line 58: |
| | | | |
| | *Low-impact, very feasible research ideas: | | *Low-impact, very feasible research ideas: |
| − | **SCD-FR | + | **SCD-PV |
| | **Better late than never PONV | | **Better late than never PONV |